Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter, Randomized, Open-label Study of Diabetes Treatment Support System (BAP0527 and Blood Glucose Meter) in Patients With Type 2 Diabetes Mellitus

NCT06156696 is registered in ClinicalTrials.gov with Astellas Pharma Inc as lead sponsor.

NCT NCT06156696
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06156696 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter, Randomized, Open-label Study of Diabetes Treatment Support System (BAP0527 and Blood Glucose Meter) in Patients With Type 2 Diabetes Mellitus
Lead sponsor
Astellas Pharma Inc
Phase
Not reported
Overall status
Completed
Start date
February 16, 2024
Completion date
September 10, 2025
Enrollment
248 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes mellitus